Helping people adhere to their varenicline treatment by co-creating a conversational agent: A feasibility study

通过共同创建对话代理来帮助人们坚持伐尼克兰治疗：可行性研究

• 批准号: 451438
• 负责人: Minian Nadia
• 金额: $ 20.34万
• 依托单位: Centre for Addiction and Mental Health (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-09-01 至 2024-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=451438&lang=en
• 关键词: Conversational Agent; Implementation Outcomes; Medication Adherence; Smoking Cessation; Conversational Agent; Implementation Outcomes; Medication Adherence; Smoking Cessation

Varenicline is a prescription medication that helps people quit smoking tobacco. When taken as prescribed, it is the most effective smoking cessation medication available in Canada. However, many people do not adhere to the 12-week regimen, and this decre

Varenicline是一种处方药，可帮助人们戒烟。按照规定，它是加拿大可用的最有效的戒烟药物。但是，许多人不遵守12周的疗法，而这一契约